A shocking financial controversy recently emerged at the Postgraduate Institute of Medical Education and Research in Chandigarh. Specifically, the notorious PGI chemist scam has highlighted deep-rooted corruption and regulatory failures within the hospital premises. An RTI query exposed how a vendor inflated a basic medical item’s cost by 978%. Subsequently, this revelation sparked intense scrutiny regarding public welfare funds and patient exploitation. For healthcare professionals committed to safe prescribing and ethical medical practice, such incidents serve as a reminder of the importance of transparency in the pharmaceutical supply chain.
The Mechanics of the PGI Chemist Scam
The fraudulent scheme involved the manipulation of Maximum Retail Price (MRP) stickers on essential medical products. For instance, the chemist procured a medical item called Innova Plast for just Rs 38. However, the vendor placed bogus labels over the original packaging to create a fake MRP of Rs 410. Consequently, unsuspecting patients purchased the item for Rs 205 under the guise of a discount. Thus, they still paid 440% more than the actual cost. Therefore, the hospital terminated the chemist’s contract on June 18, 2025. Ensuring that patients have access to affordable, authentic medications is a cornerstone of modern general practice.
Misappropriation of Patient Welfare Grants
This pharmacy fraud directly links to a larger Rs 1.14 crore welfare fund scandal at the institute. Originally, the scam came to light when a patient’s husband tried to secure medicines using a welfare grant. Meanwhile, a digital investigation revealed that a clerk had intentionally destroyed relevant physical files to hide illegal transfers. Specifically, the clerk siphoned over Rs 2 lakh into a private account. Later, an internal inquiry committee exposed a corrupt nexus of public servants and local chemists.
Regulatory Reforms and CBI Investigation
Although the committee noticed the scam in early 2023, it took fifteen months to submit its report. Subsequently, a persistent citizen filed a formal RTI request to obtain these findings. Therefore, the Chief Vigilance Officer quickly escalated the case to the Central Bureau of Investigation (CBI). To prevent future fraud, the hospital has now overhauled its procurement systems. Furthermore, they implemented a strict policy to eliminate third-party intermediaries completely. Developing robust management skills is often part of a foundation comprehensive training for new doctors looking to navigate complex healthcare environments.
Frequently Asked Questions
Q1: What was the primary item manipulated in the PGI chemist scam?
The chemist primarily manipulated the pricing of a medical consumable called Innova Plast. Specifically, they inflated its cost from Rs 38 to a fake MRP of Rs 410 using fraudulent stickers.
Q2: How did the hospital respond to the uncovered price manipulation?
The hospital terminated the vendor’s contract in June 2025. Additionally, authorities referred the entire financial misappropriation case to the Central Bureau of Investigation for a detailed criminal probe.
References
- PGI scam: Chemist inflated Rs 38 item to Rs 410 with bogus labels – ETHealthworld
- CBI registers case against eight, including six PGIMER employees, in patient welfare grant scam – The New Indian Express
- PGI Chandigarh overhauls procurement system after AB-PMJAY scam – Medical Buyer
Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.